Evidence for clinical and quality of life benefits of Continuous Glucose Monitor (CGM) use in patients with type 1 diabetes (T1DM) is well established, but evidence in patients with type 2 diabetes (T2DM) is less robust or clear. This study aimed to help clarify the impact of CGMs for patients with T2DM and possible factors to such potential impact.Adult patients with T2DM who filled a CGM prescription for the first time within the previous 12 months were identified as potential participants for our mixed-methods study. Exploratory interviews were conducted first to gain insight and aid in developing a new CGM impact survey to address gaps in existing measures. That survey was then administered to a larger sample from our identified patients.Our T2DM respondents experienced a reduction in A1c, improved glucose control, and better overall health and quality of life from CGM use but did not experience a reduction in the number of hypoglycemia episodes.Beyond the support our study adds to findings from previous studies as to the clinical and quality of life impact of CGM use for patients with T2DM, it also identifies increases in self-care behaviors as another area of CGM impact, an area largely missing in previous studies, and positions self-care behaviors and self-care support factors (diabetes knowledge and health self-efficacy) as a, or the, key variable between T2DM patients’ experience in using CGMs (e.g., ease of use and quality of data) and their ultimate clinical and health/quality of life outcomes from using the devices.

BACKGROUND AND OBJECTIVES:The translation of research findings into routine care remains slow and challenging. We previously reported successful implementation of an asthma evidence-based care process model (EB-CPM) at 8 (1 tertiary care and 7 community) hospitals, leading to a high health care provider (HCP) adherence with the EB-CPM and improved outcomes. In this study, we explore contextual factors perceived by HCPs to facilitate successful EB-CPM implementation.METHODS:Structured and open-ended questions were used to survey HCPs (n = 260) including physicians, nurses, and respiratory therapists, about contextual factors perceived to facilitate EB-CPM implementation. Quantitative analysis was used to identify significant factors (correlation coefficient ≥0.5; P ≤ .05) and qualitative analysis to assess additional facilitators.RESULTS:Factors perceived by HCPs to facilitate EB-CPM implementation were related to (1) inner setting (leadership support, adequate resources, communication and/or collaboration, culture, and previous experience with guideline implementation), (2) intervention characteristics (relevant and applicable to the HCP's practice), (3) individuals (HCPs) targeted (agreement with the EB-CPM and knowledge of supporting evidence), and (4) implementation process (participation of HCPs in implementation activities, teamwork, implementation team with a mix of expertise and professional's input, and data feedback). Additional facilitators included (1) having appropriate preparation and (2) providing education and training.CONCLUSIONS:Multiple factors were associated with successful EB-CPM implementation and may be used by others as a guide to facilitate implementation and dissemination of evidence-based interventions for pediatric asthma and other chronic diseases in the hospital setting.